(Reuters) -Drugmaker AbbVie said on Friday it has lowered its annual profit forecast, after flagging an expected $2.7 billion charge related to in-process research and development (IPR&D) expenses in ...
AbbVie (NYSE:ABBV) is set to report its Q2 earnings on Thursday, July 31, before the market opens. Analysts are expecting earnings per share of $2.91, reflecting a 9.8% year-over-year increase, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback